## KMX: CarMax Inc - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.60 indicates fundamental undervaluation. Caution: momentum weakening (-10.6% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($35.16)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 7)

**1. CarMax Bets On Lower Prices To Jumpstart Sales After 47% Profit Drop**
- Source: Benzinga | 20251219T163036 | Somewhat-Bearish | Relevance: 100%
- CarMax (NYSE: KMX) reported a 47% drop in fiscal third-quarter profits and is planning to cut prices to revive unit growth, according to analyst reports from Stephens and RBC Capital Markets. Stephens noted a 9% decline in same-store units and a 3.1% contraction in retail gross profit per unit, while RBC highlighted CarMax's efforts to reduce SG&A expenses and strong performance in older, higher-mileage vehicles. Analysts have adjusted price targets for KMX shares, which were down following the earnings report.

**2. KMX 2-WEEK DEADLINE ALERT: CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman**
- Source: PR Newswire | 20251219T142631 | Bearish | Relevance: 100%
- Hagens Berman reminds CarMax (NYSE: KMX) investors that the deadline to move for lead plaintiff in a securities class action lawsuit is January 2, 2026. The lawsuit alleges CarMax and its executives issued false and misleading information by failing to disclose that strong Q1 2026 growth was a temporary "pull forward" of customer demand and that its loan portfolio faced significant undisclosed risks. The lawsuit claims these misrepresentations led to dual stock crashes, and Hagens Berman is investigating these alleged undisclosed business weaknesses.

**3. CarMax Q3 Earnings Surpass Expectations, Revenues Decline Y/Y**
- Source: TradingView â€” Track All Markets | 20251219T130825 | Neutral | Relevance: 100%
- CarMax (KMX) reported adjusted earnings of 51 cents per share for the third quarter of fiscal 2026, surpassing the Zacks Consensus Estimate of 32 cents, despite a decline from 81 cents in the previous year. Revenues totaled $5.8 billion, exceeding expectations but representing a 6.9% year-over-year decrease. The company's performance in used-vehicle sales and wholesale vehicle revenues showed mixed results, with unit sales falling but average selling prices and gross profit per unit often beating estimates.

**4. CarMax Shareholder Alert: ClaimsFiler Reminds Investors**
- Source: GlobeNewswire | 20251218T170314 | Bearish | Relevance: 100%
- ClaimsFiler is reminding investors that they have until January 2, 2026, to file lead plaintiff applications in a securities class action lawsuit against CarMax, Inc. (NYSE: KMX). The lawsuit alleges that CarMax and its executives failed to disclose material information during the Class Period (June 20, 2025, to November 5, 2025), leading to a significant drop in share price after the Q2 Fiscal Year 2026 financial results were announced. Investors who suffered losses in excess of $100,000 are encouraged to visit ClaimsFiler for more information.

**5. KMX Earnings: CarMax Stock Plunges on Profit Trade-Off Plan despite Q3 Beat**
- Source: TipRanks | 20251218T130845 | Bearish | Relevance: 100%
- CarMax's stock (KMX) fell over 7% despite beating Q3 2026 earnings and revenue estimates, as the company announced a strategy to sacrifice profit margins to boost sales. This decision to prioritize sales through aggressive pricing and increased marketing efforts comes amidst significant declines in retail and wholesale volumes, and ongoing leadership changes, causing investor concern about short-term profitability. Analysts currently hold a "Moderate Buy" consensus rating with a 3% downside risk from current levels.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 4, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Barclays | $24 | $28 | -14% |
| 2025-12-19 | Truist Securiti | $37 | $35 | +6% |
| 2025-12-19 | B of A Securiti | $31 | $27 | +15% |
| 2025-12-19 | JP Morgan | $28 | $30 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Barclays | main | Underweight |
| 2025-12-19 | Truist Securiti | main | Hold |
| 2025-12-19 | B of A Securiti | main | Underperform |
| 2025-12-19 | JP Morgan | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Elevated short interest (11.8%): bears positioning against stock.
2. Long-term trend broken: trading 33.3% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Analyst target momentum: 4 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.60 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (5 target cuts vs 4 raises). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.5B |
| Beta | 1.29 |
| 52W Range | $30.26 - $89.47 |
| Short Interest | 11.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.60 |
| Forward P/E | 14.6 |
| Current P/E | 14.4 |
| YoY Growth | -1.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 8.7% to -2.0% (-10.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.0pp (needs >4.0% for momentum thesis). Underperforming sector by 4.1pp, stock-specific weakness. Below SMA200 (0.67x), long-term trend not supportive. RSI neutral at 46. Elevated volume (2.3x 20MA), institutional activity likely. OFD pattern: +DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.97% (CS: 28) | Neutral |
| RSI_14 | 45.7 | Neutral |
| MACD Histogram | 0.15 | Bullish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 0.976x | Below |
| vs SMA200 | 0.667x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $38.44
- **Stop Loss:** $35.16 (8.5% risk)
- **Target:** $45.00 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 274
- **Position Value:** $10,532.56
- **Portfolio %:** 10.53%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |
| 2024Q4 | $0.61 | $0.81 | +33.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*